Cargando…
Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer
This study aimed to investigate the effects of luteolin on colorectal cancer (CRC) and explore its underlying mechanism. HCT-116 and HT-29 cells were treated with luteolin, cisplatin, or selumetinib. The cell survival, cell proliferation, apoptosis and cell cycle distribution, and DNA damage were de...
Autores principales: | Song, Yelin, Yu, Jie, Li, LingLing, Wang, Lei, Dong, Liangle, Xi, Guangmin, Lu, Yun Jing, Li, Zuowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161897/ https://www.ncbi.nlm.nih.gov/pubmed/35473479 http://dx.doi.org/10.1080/21655979.2022.2066926 |
Ejemplares similares
-
Luteolin reduces cardiac damage caused by hyperlipidemia in Sprague-Dawley rats
por: Dong, Min, et al.
Publicado: (2023) -
Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine
por: Xu, Ling, et al.
Publicado: (2021) -
WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling
por: Cai, Juanjuan, et al.
Publicado: (2022) -
Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy
por: Luo, Hao-Yun, et al.
Publicado: (2022) -
Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-κB/mitogen-activated protein kinases pathway
por: Nepali, Sarmila, et al.
Publicado: (2015)